Business Wire

Peripheral Vascular Devices Market Forecast Report and Company Analysis 2024-2032 Featuring Abbott Laboratories, Boston Scientific, BD & Co, Cook, Cordis, Edward Lifesciences ...

DUBLIN--(BUSINESS WIRE)--The "Peripheral Vascular Devices Market Report, Forecast by Device Type, Country and Company Analysis 2024-2032" report has been added to ResearchAndMarkets.com's offering.
Medscape

Drug-Coated Devices Failed to Improve Outcomes in Peripheral Artery Disease

Drug-coated stents and balloons were not associated with a reduction in amputations or improved quality of life compared with uncoated devices among patients with peripheral artery disease, according ...
Healio

Studies cast doubt on drug-coated devices for treatment of peripheral artery disease

Please provide your email address to receive an email when new articles are posted on . Drug-coated devices did not improve amputation rates vs. uncoated devices in patients with limb-threatening ...
BioWorld

FDA declines to clarify status of accessories in peripheral vascular devices final guidance

The U.S. FDA has finalized a guidance for class II devices for treatment of peripheral artery disease that excludes drug-coated balloons (DCBs), which are regulated as class III devices. One of the ...
EDN

Smart-Meter Solutions Include Low-Energy Microcontrollers, Robust Security Technology, and a Wide Range of Peripheral Devices

Smart meters are key parts of the smart-grid power-distribution networks now being rolled out internationally to achieve economic and environmental benefits. Traditional energy meters are mechanical, ...
EurekAlert!

Drug-coated devices do not improve outcomes in patients with peripheral artery disease

Madrid, Spain – 31 August 2025: Drug-coated stents and balloons were not associated with reduced risk of amputation or improved quality of life compared with uncoated devices in two trials in ...